Skip to content

AngioDynamics ANGO Gross Profit

Gross Profit at other companies

Abbott logo
AbbottABT
$6.27B+6.5%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$2.15B+15.7%
TFX
TeleflexTFX
$307.43M+20.4%
Stryker logo
StrykerSYK
$3.81B+1.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$184.8M+7.4%
ICU Medical logo
ICU MedicalICUI
$206.23M-1.8%

Segments

By segment

See full
Med Tech$23.29M+18.9%
Med Device$18.19M-5.6%

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0.0×
Current ratio2.4×+0.1×

Where this comes from

Calculated from AngioDynamics’s reported figures.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's gross profit?
AngioDynamics (ANGO) reported gross profit of $41.48M in Q4 2025.
How has AngioDynamics's gross profit changed year-over-year?
AngioDynamics's gross profit increased by 6.7% year-over-year, from $38.86M to $41.48M.
What is the long-term trend for AngioDynamics's gross profit?
Over 4 years (2021 to 2025), AngioDynamics's gross profit has grown at a 0.1% compound annual growth rate (CAGR), from $156.79M to $157.71M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.